adjuvanted tuberculosis subunit vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00929396)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adjuvanted tuberculosis subunit vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06438978 | Phase 1 | Jan 19, 2024 | Bharat Biotech International Limited |
| NCT00929396 | Phase 1 | Sep 1, 2007 | Leiden University, Statens Serum Institut |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bharat Biotech International Limited | For profit | 1 | 1 | 1 | 2024 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Statens Serum Institut | Academic/Hospital | 1 | 1 | 1 | 2007 |
3 organizations
Page 1 / 1